Technology to kill metastatic cancer cells licensed for development
Wednesday, August 24, 2016 - 15:01
in Health & Medicine
Stephen FellerORLANDO, Fla., Aug. 24 (UPI) -- UCF researchers have licensed a unique peptide for development after it showed promise at killing metastatic breast cancer cells, researchers report in a study.